Generic Pazopanib is now available in the Philippines through Getmeds with PAZOGET, the first generic Pazopanib in the country.
For Filipino patients living with advanced renal cell carcinoma (RCC) or advanced soft tissue sarcoma (STS), access to targeted cancer therapy has long been limited by one major barrier: cost. Until recently, pazopanib in the Philippines was only available as the originator brand, putting consistent treatment out of reach for many families. That landscape is now changing.
Getmeds is proud to introduce PAZOGET — the first generic pazopanib in the Philippines, available in two strengths: PAZOGET 200 mg and PAZOGET 400 mg. By offering a quality-assured generic alternative, PAZOGET aims to make long-term, evidence-based cancer treatment more affordable and sustainable for Filipino patients and their families.
In this guide, we’ll walk through what pazopanib is, how it works, what it treats, its side effect profile, and what the arrival of PAZOGET means for pazopanib price and access in the Philippines.
What Is Pazopanib?
Pazopanib is an oral, targeted anti-cancer medication belonging to a class of drugs known as tyrosine kinase inhibitors (TKIs). Unlike traditional intravenous chemotherapy, pazopanib is taken as a tablet at home and works by specifically blocking signaling pathways that cancer cells use to grow and spread.
Pazopanib was first approved internationally for the treatment of:
- Advanced Renal Cell Carcinoma (RCC) — the most common type of kidney cancer in adults.
- Advanced Soft Tissue Sarcoma (STS) — in patients who have previously received chemotherapy (with some subtype exceptions, such as adipocytic sarcoma).
It is typically prescribed by an oncologist as part of a broader cancer management plan and is intended for long-term, continuous use until disease progression or unacceptable toxicity.
Is Pazopanib Chemotherapy?
This is one of the most common questions patients ask, and the answer is nuanced.
Pazopanib is not traditional cytotoxic chemotherapy. Classical chemotherapy works by killing rapidly dividing cells throughout the body, which is why it often causes hair loss, severe nausea, and bone marrow suppression. Pazopanib, on the other hand, is classified as a targeted therapy — it interferes with specific molecules involved in tumor growth and blood vessel formation.
That said, in many clinical settings the term “chemotherapy” is used broadly to include any systemic anti-cancer drug, including targeted oral agents like pazopanib. So while technically pazopanib is a targeted oral anti-cancer therapy, your oncologist may still refer to it as part of your “chemo regimen” in a general sense.
Pazopanib Mechanism of Action
Understanding the pazopanib mechanism of action helps explain why it is effective against certain cancers.
Pazopanib is a multi-targeted tyrosine kinase inhibitor. It blocks several receptors involved in tumor growth and angiogenesis (the formation of new blood vessels that feed tumors), including:
- VEGFR-1, VEGFR-2, and VEGFR-3 (Vascular Endothelial Growth Factor Receptors)
- PDGFR-α and PDGFR-β (Platelet-Derived Growth Factor Receptors)
- FGFR-1 and FGFR-3 (Fibroblast Growth Factor Receptors)
- c-Kit (Stem Cell Factor Receptor)
By inhibiting these targets, pazopanib essentially “starves” the tumor by cutting off its blood supply and disrupting the signals it needs to proliferate. This is why it has become an established treatment option for highly vascular tumors such as renal cell carcinoma.
Pazopanib Treatment: Approved Indications
Pazopanib treatment is most commonly prescribed for two conditions:
1. Advanced Renal Cell Carcinoma (RCC)
Pazopanib is used as a first-line or subsequent-line therapy in patients with locally advanced or metastatic RCC. Clinical trials have demonstrated improvements in progression-free survival compared to placebo, and comparable efficacy to other first-line TKIs.
2. Advanced Soft Tissue Sarcoma (STS)
Pazopanib is approved for patients with selective subtypes of advanced STS who have received prior chemotherapy. It is one of the few oral targeted therapies available for this difficult-to-treat group of cancers.
Important: Pazopanib is only indicated for specific cancer types and should never be self-prescribed. Always follow the treatment plan set by your oncologist.
PAZOGET 200 mg and PAZOGET 400 mg: Available Strengths
PAZOGET is available in two tablet strengths to provide dosing flexibility:
- PAZOGET 200 mg — Useful for dose adjustments, dose reductions due to side effects, or for patients starting on a lower titration.
- PAZOGET 400 mg — A higher-strength tablet that allows patients on the standard dose to take fewer tablets per day.
The standard recommended dose of pazopanib is 800 mg once daily, taken on an empty stomach (at least 1 hour before or 2 hours after a meal). However, your oncologist may adjust the dose based on your liver function, side effects, or individual response.
Having both 200 mg and 400 mg strengths means doctors can fine-tune therapy — for example, prescribing 600 mg or 400 mg daily when dose reductions are needed.
Pazopanib Price in the Philippines: Why Generic Availability Matters
One of the biggest barriers to consistent cancer treatment in the Philippines has been the cost of long-term targeted therapy. Patients on pazopanib typically take the drug daily, often for many months or even years, making monthly medication expenses a significant burden.
Before the arrival of PAZOGET, pazopanib price in the Philippines was largely dictated by the originator brand’s pricing — a cost that placed it beyond the reach of many Filipino families, especially those without comprehensive private insurance.
How Generics Improve Affordability
A generic medication contains the same active pharmaceutical ingredient (API), in the same dosage form and strength, as the originator brand. Generics must meet rigorous quality and bioequivalence standards set by the Philippine Food and Drug Administration (FDA).
The introduction of PAZOGET as the first generic pazopanib in the Philippines brings several potential benefits:
- Lower out-of-pocket cost for monthly therapy compared to originator pricing.
- Improved treatment continuity — patients are less likely to skip doses or stop treatment due to financial strain.
- Wider access for patients in provincial areas through online ordering and delivery.
- More room within insurance and PhilHealth-supported budgets, potentially extending the duration of treatment patients can sustain.
For the most current pazopanib 400 mg price and PAZOGET 200 mg price, we recommend contacting Getmeds directly, as pricing may vary depending on quantity, prescription validity, and ongoing patient access programs.
Pazopanib Side Effects: What to Watch For
Like all targeted cancer therapies, pazopanib can cause side effects. Knowing what to expect — and what is serious — helps patients stay on treatment safely.
Common Pazopanib Side Effects
Many patients experience some of the following:
- Diarrhea
- High blood pressure (hypertension)
- Nausea or vomiting
- Decreased appetite
- Fatigue
- Hair color changes (lightening or depigmentation)
- Headache
- Abdominal pain
- Changes in taste
How to Buy Generic Pazopanib in the Philippines from Getmeds
Getmeds is committed to expanding access to specialty and oncology medications across the Philippines. With PAZOGET, patients can now order their pazopanib treatment more conveniently and at a more affordable price point.
To purchase PAZOGET 200 mg or PAZOGET 400 mg through Getmeds:
- Secure a valid prescription from your oncologist or attending physician.
- Contact Getmeds through their official platform to inquire about availability and current pricing.
- Submit your prescription for verification (required for all prescription-only medications).
- Arrange delivery to your home or preferred address anywhere in the Philippines.
This streamlined process is especially helpful for patients in provinces or in areas where specialty oncology pharmacies are limited.
Get in Touch with Getmeds
For inquiries about PAZOGET availability, pricing, and orders, you can reach the Getmeds team through:
Phone/Viber: 09190769105
Email: info@getmeds.ph
Frequently Asked Questions (FAQ)
Is PAZOGET the same as the originator pazopanib?
PAZOGET contains the same active ingredient (pazopanib) as the originator brand and must meet Philippine FDA bioequivalence and quality standards as a registered generic.
Is pazopanib considered chemotherapy?
Pazopanib is a targeted therapy (tyrosine kinase inhibitor), not traditional cytotoxic chemotherapy. However, it is a systemic anti-cancer drug and is often discussed alongside chemotherapy treatments.
What is the standard dose of pazopanib?
The usual starting dose is 800 mg once daily, taken on an empty stomach. Your oncologist may adjust the dose based on side effects, liver function, or other clinical factors.
Can pazopanib cure cancer?
Pazopanib is not a cure. It is used to control advanced cancers, slow progression, and extend survival or improve quality of life in eligible patients.
How long do patients take pazopanib?
Treatment is usually continued until disease progression or until side effects become unmanageable. Some patients remain on therapy for many months or years.
Where can I find the current pazopanib 400 mg price in the Philippines?
The most accurate and updated pazopanib 400 mg price can be obtained directly from Getmeds, as prices may change based on supply, programs, and dispensed quantities.
A Step Forward for Filipino Cancer Patients
The arrival of PAZOGET — the first generic pazopanib in the Philippines — represents more than just a new product on a pharmacy shelf. It represents a step toward more equitable cancer care, where Filipino patients are not forced to choose between continuing life-extending treatment and protecting their family’s financial stability.
By offering pazopanib in both 200 mg and 400 mg strengths through Getmeds, patients and oncologists now have a more affordable, locally accessible option to support consistent, long-term treatment.
If you or a loved one has been prescribed pazopanib, speak with your oncologist about whether PAZOGET is right for you, and reach out to Getmeds for information on availability and pricing.
Medical Disclaimer
This article is intended for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Pazopanib (PAZOGET) is a prescription-only medication and must be used strictly under the supervision of a qualified oncologist or licensed physician. Always read the official package insert, follow your doctor’s instructions, and report any side effects to your healthcare provider. Do not start, stop, or modify any cancer treatment without consulting your medical team.